Get the Stockscreener App
17.36
1.88%
0.32
Pre-market:
17.32
-0.04
-0.23%
Surgery Partners Inc stock is traded at $17.36, with a volume of 617.38K.
It is up +1.88% in the last 24 hours and down -21.09% over the past month.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.
See More
Previous Close:
$17.04
Open:
$16.97
24h Volume:
617.38K
Relative Volume:
0.37
Market Cap:
$2.25B
Revenue:
$2.89B
Net Income/Loss:
$-33.80M
P/E Ratio:
-64.30
EPS:
-0.27
Net Cash Flow:
$204.10M
1W Performance:
+1.76%
1M Performance:
-21.09%
6M Performance:
-24.72%
1Y Performance:
-22.91%
1-Day Range:
$16.80
$17.44
1-Week Range:
$16.71
$17.46
52-Week Range:
$14.94
$26.16
Surgery Partners Inc Stock (SGRY) Company Profile
Name
Surgery Partners Inc
Sector
Industry
Phone
615-234-5900
Address
310 SEVEN SPRINGS WAY, BRENTWOOD, TN
Compare SGRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGRY
Surgery Partners Inc
|
17.36 | 2.20B | 2.89B | -33.80M | 204.10M | -0.27 |
|
HCA
Hca Healthcare Inc
|
487.66 | 111.08B | 74.37B | 7.31B | 8.10B | 25.88 |
|
THC
Tenet Healthcare Corp
|
212.14 | 18.57B | 20.69B | 2.40B | 1.55B | 15.62 |
|
UHS
Universal Health Services Inc
|
230.59 | 14.38B | 16.08B | 1.20B | 1.06B | 17.82 |
|
FMS
Fresenius Medical Care Ag Adr
|
23.37 | 13.66B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
EHC
Encompass Health Corp
|
113.02 | 11.37B | 5.51B | 494.70M | 386.40M | 4.84 |
Surgery Partners Inc Stock (SGRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Resumed | JP Morgan | Neutral |
| Jul-28-25 | Resumed | BofA Securities | Buy |
| Dec-16-24 | Initiated | BofA Securities | Buy |
| Oct-14-24 | Initiated | UBS | Buy |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-28-24 | Initiated | Macquarie | Outperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Nov-14-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Jun-02-23 | Upgrade | BofA Securities | Neutral → Buy |
| May-12-23 | Initiated | Mizuho | Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-23-22 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-15-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-10-22 | Resumed | Citigroup | Buy |
| Nov-30-21 | Initiated | Barclays | Overweight |
| Nov-29-21 | Upgrade | Stifel | Hold → Buy |
| Nov-01-21 | Initiated | JP Morgan | Neutral |
| Oct-18-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Jun-23-21 | Resumed | Stifel | Hold |
| Sep-17-20 | Reiterated | The Benchmark Company | Buy |
| Apr-27-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Mar-03-20 | Downgrade | The Benchmark Company | Buy → Hold |
| Jan-14-20 | Reiterated | The Benchmark Company | Buy |
| Nov-16-18 | Initiated | UBS | Neutral |
| Sep-18-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jun-28-18 | Upgrade | Stifel | Sell → Hold |
| Jan-30-18 | Reiterated | The Benchmark Company | Buy |
| Nov-01-17 | Downgrade | BofA/Merrill | Buy → Neutral |
| Aug-09-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Aug-09-17 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Aug-09-17 | Downgrade | Stifel | Hold → Sell |
| Apr-24-17 | Reiterated | Stifel | Hold |
| Mar-10-17 | Downgrade | Stifel | Buy → Hold |
| Jan-31-17 | Initiated | The Benchmark Company | Buy |
| Jun-10-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Mar-14-16 | Reiterated | RBC Capital Mkts | Outperform |
| Oct-27-15 | Initiated | Stifel | Buy |
| Oct-26-15 | Initiated | RBC Capital Mkts | Outperform |
| Oct-26-15 | Initiated | Raymond James | Strong Buy |
View All
Surgery Partners Inc Stock (SGRY) Latest News
What dividend safety score for Surgery Partners Inc. stockWeekly Investment Recap & Stock Timing and Entry Methods - Newser
Why analysts remain bullish on Surgery Partners Inc. stockWeekly Trade Summary & Weekly Hot Stock Watchlists - Newser
Published on: 2025-12-04 13:42:49 - Newser
Surgery Partners, Inc. (SGRY) Under Investigation for Potential Securities Law ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
How Surgery Partners Inc. stock reacts to global recession fears2025 Volume Leaders & Free High Return Stock Watch Alerts - Newser
Surgery Partners, Inc. (NASDAQ:SGRY) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Can Surgery Partners Inc. stock maintain growth trajectory2025 Analyst Calls & Free Daily Entry Point Trade Alerts - moha.gov.vn
Surgery Partners' takeover offer should rekindle interestanalyst - MSN
History Review: How supply chain issues affect Surgery Partners Inc. stockJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - moha.gov.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Surgery Partners, Inc. (SGRY) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Surgery Partners, Inc. (SGRY) And Encourages Shareholders to Reach Out - ACCESS Newswire
Assessing Surgery Partners (SGRY) Valuation Following Fed-Driven Investor Optimism and Recent Share Price Rebound - Yahoo Finance
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - Finviz
JP Morgan Lowers Surgery Partners (SGRY) Price Target to $20 | S - GuruFocus
Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Barclays Keeps Their Hold Rating on Surgery Partners (SGRY) - The Globe and Mail
Zoetis and Surgery Partners Shares Are Soaring, What You Need To Know - The Globe and Mail
SGRY Analyst Rating Update: Barclays Lowers Price Target to $18. - GuruFocus
Surgery Partners, Inc. (SGRY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Surgery Partners (SGRY): Assessing Valuation After Recent 27% Share Price Drop - sahmcapital.com
Why Surgery Partners Inc. stock is favored by pension fundsProfit Target & Fast Exit/Entry Strategy Plans - newser.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Surgery Partners, Inc. (SGRY) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Surgery Partners, Inc. (SGRY) And Encourages Investors to Connect - ACCESS Newswire
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc.SGRY - MarketScreener
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc.SGRY - cnhinews.com
Surgery Partners price target lowered to $22 from $28 at Mizuho - MSN
Is Surgery Partners Inc. stock recession proofJuly 2025 Short Interest & Low Risk Growth Stock Ideas - newser.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Surgery Partners, Inc. (SGRY) And Encourages Stockholders to Reach Out - ACCESS Newswire
Can Surgery Partners Inc. stock sustain market leadershipQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Surgery Partners, Inc. (SGRY) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
What data driven models say about Surgery Partners Inc.’s futureMarket Activity Report & Low Risk Growth Stock Ideas - newser.com
3 Reasons to Sell SGRY and 1 Stock to Buy Instead - Yahoo Finance
Automated trading signals detected on Surgery Partners Inc.Portfolio Growth Summary & Weekly Sector Rotation Insights - newser.com
Surgery Partners Inc. stock momentum explained2025 Market Trends & Safe Swing Trade Setups - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Surgery Partners, Inc. (SGRY) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
AirSculpt Technologies Appoints Mike Doyle as Non-Executive Chairman of the Board - GlobeNewswire Inc.
Mizuho lowers Surgery Partners stock price target on payer mix concerns - Investing.com Canada
Surgery Partners stock hits 52-week low at $15.09 - Investing.com
Surgery Partners stock hits 52-week low at $15.09 By Investing.com - Investing.com South Africa
Mizuho Lowers Price Target for Surgery Partners (SGRY) While Mai - GuruFocus
Surgery Partners: Surgery Partners, Inc.Flex Position Consolidation Option Symbol: 1SGRY - 富途牛牛
Developing predictive dashboards with Surgery Partners Inc. dataPortfolio Update Summary & Daily Stock Momentum Reports - newser.com
Using RSI to spot recovery in Surgery Partners Inc.Earnings Trend Report & Precise Trade Entry Recommendations - newser.com
Will Surgery Partners Inc. benefit from macro trendsTrade Entry Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Surgery Partners Inc Stock (SGRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.75%
0.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):